Artificial pancreas devices so far cannot compensate the daily varying food intake or physical activities of diabetes patients. The University of Bern, the Bern University Hospital and an industry partner have therefore set out to develop a more flexible device to continuously control patients’ blood sugar.
"Today, a diabetic patient must follow a very constraining therapy with many blood glucose measurements, dose calculations and insulin injections. The ideal would be to have a single system that can conduct all of these operations without requiring any intervention", says Prof. Peter Diem, Chairman and Head of the Department of Endocrinology, Diabetes and Clinical Nutrition at Inselspital.
Such a system needs to continuously measure and calculate the level of glucose present in the blood and to constantly deliver insulin via an infusion pump. The amount of infused insulin is determined by an algorithm that estimates the patient needs based on the measured glucose levels, the time of day or the expected activities and that will adapt the pump infusion rate accordingly.
Insulin need depends on daily activity and food profile
"Approaches taken so far do not resolve fundamental difficulties: the patients' variability, uncertainties related to system disturbances, e.g. food intake and physical activity, and errors related to the used devices,” says Dr. Stavroula Mougiakakou, Head of the Diabetes Technology Research Group at the University of Bern’s ARTORG Center.
“The proposed algorithm is easy to use, introduces the concept of real-time personalisation based on reinforcement learning, is able to tackle inter- and intra-patient variability, and can compensate for the effects of uncertain events."
Artificial pancreas has to work accurately and flexibly
The new artificial pancreas ARTORG and Inselspital wish to develop will include an infusion pump produced by an industry partner and an algorithm to run on a wireless PDA device used for the programming of the pump. The accuracy of the different elements in an artificial pancreas is critical.
The insulin levels have to be maintained in a very narrow window. Too little insulin will lead to hyperglycaemia, while too much insulin generates hypoglycaemia. Both situations may induce coma and even patient death. The proposed pump therefore emphasizes on accuracy and flexibility.
The patch pump will be directly placed on the skin, to continuously monitor therapy. It can be detached and reattached at will. A prototype of the pump has been tested by patients in a first clinical trial. After development and integration, the new control algorithm for the personalised delivery of insulin will be verified in a number of clinical trials.
"We are looking forward to seeing this new approach being used by patients and appreciate how much this may facilitate their treatment. It is even more important to improve their quality of life", says Prof. Christoph Stettler, newly elected Director of the Division of Endocrinology, Diabetes and Clinical Nutrition at Inselspital.
On diabetes therapy:
Prof. Dr.med. Peter Diem, Chairman and Head, Division of Endocrinology, Diabetes and Clinical Nutrition, Inselspital, Bern University Hospital, +41 31 632 4070, email@example.com.
On the algorithm:
PD Dr. Stavroula Mougiakakou, ARTORG Center - Diabetes Technology Research, +41 31 632 75 92, firstname.lastname@example.org.
On the infusion pump:
Laurent-Dominique Piveteau, Press Contacts, Debiotech SA, +41 21 623 60 00, email@example.com.
Monika Kugemann | Universitätsspital Bern
How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine
Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center
On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.
We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...
What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...
For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.
Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...
At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.
No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...
Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.
Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...
08.01.2018 | Event News
11.12.2017 | Event News
08.12.2017 | Event News
22.01.2018 | Materials Sciences
22.01.2018 | Earth Sciences
22.01.2018 | Life Sciences